About Intas B2B
Since March 2005, Intas B2B has become an active pharmaceutical licensor, proud to supply more than 150 different finished products to 100+ partners in EMEA, APAC, CANADA and LATAM.
GMP sites approved by key Health Authorities
Cost efficient & large manufacturing capabilities
Long experience in license & supply to regulated markets
Wide portfolio and innovative pipeline
Fully fledged team for customers’ satisfaction
For more information about IntasB2B or enquiries about our dossiers, please contact us
About Intas Group
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies, with presence in more than 85 countries across the world.
Currently ranked 6th (as per IQVIA TSA MAT January 2024) in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company.
Over the years, Intas has grown both organically and via acquisition, expanding its product portfolio and operations. The company is composed by a full fledged global support team of 18,000+ employees.
Billion Turnover
$
.4
CAGR Growth
%
cGMP manufacturing sites approved for US and EU
